65,437 trials
Tobacco Use Cessation
Primary: Number of Subjects With a 4 Week Continuous Quit Rate (CQR) From Smokeless Tobacco — 125; 85 participants — p=<0.0001
Surgery
Primary: Surgery Site CFU Density — 7; 11; 0 CFU/cubic meter — p=<0.001
Epilepsy, Tonic-Clonic
Primary: Percent Change From Baseline in Weekly Primary Generalized Tonic-clonic (PGTC) Seizure Frequency During the Entire Double-Blind Treatment Phase — 32.1; 75.4 percent…
Crohn's Disease
Primary: Number of Randomized Participants Achieving Clinical Remission at Week 56 - Non-Responder Imputation (NRI) — 6; 9; 12 Participants — p=0.142
Hepatitis C, Chronic · Hepacivirus
Primary: Number of Participants Who Complete Treatment With PegIntron Pen/Rebetol Therapy for Hepatitis C When Administered With a Patient Assistance Program — 298; 75 Participants
Contraception
Primary: Bioequivalence of Implanon® and Radiopaque Implanon. — 2296; 2290; 5954; 6131 pg•month/mL — p=0.05
Healthy
Primary: Cmax — 2.8358; 2.9768 µg/mL
Schizophrenia
Primary: Summary of Schizophrenia — 1; 5; 9; 39 Participants
Non-Small Cell Lung Cancer
Primary: Median Progression Free Survival (PFS) in Months — 5.7; 5.8 Months
Glioma · Astrocytoma · Oligodendroglioma
Primary: Percentage of Participants Surviving at Six Months of Treatment Without Evidence of Disease Progression. — 35.7; 27.3; 7.4; 35.7 Percentage of Participants
Seasonal Allergic Rhinitis
Primary: Change From Baseline in the Average AM Instantaneous (NOW) Total Nasal Symptom Score (TNSS) Averaged Over Days 2 to 15 — 9.83; 9.69; -2.36; -1.71 units on a scale…
Hepatitis C, Chronic · Substance Abuse, Intravenous
Primary: Number of Drug-substituted Participants Who Achieved Sustained Virological Response (SVR) With PegIntron 1.5 μg/kg/Week and Rebetol (10.6 mg/kg/Day) in Substitution…
HIV Infections · Sexually Transmitted Diseases
Primary: Any Unprotected Anal Intercourse (UAI) With Casual Partners — 2.0; 6.2 Number of episodes — p=< 0.05
Renal Transplantation
Primary: Nankivell Glomerular Filtration Rate (GFR) — 24.56; 27.24; 59.04; 57.73 mL/min — p=0.575
Fungal Infection · Acute Myelogenous Leukemia · Neutropenia
Primary: Mean POS Plasma Concentrations on Days 2, 3, and 8. — 230; 346; 637 ng/mL